Back to Atlas
CTransientStandard research/education caution
CMP-0405
Investigational
OPK-88004
Ergogenic / SARM
Androgen-deficiency and metabolic research positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- SARM
- Primary mechanism
- Selective androgen receptor agonism
- Primary market use
- Hypogonadism / performance misuse
Pharmacology
- Molecular weight (Da)
- Not consistently disclosed
- Oral bioavailability
- Oral clinical candidate
- Half-life
- Not consistently disclosed
- Route tags
- Route-dependent / verify
- Evidence level
- Human/Clinical
- Clinical status
- Investigational
- Value-for-money score
- 3 / 10
Reported protocol signal
No popular protocol verified yet; keep as reference compound until protocol signal is added.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
Clinical-stage SARM; limited public PK